BNP Paribas Asset Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.4K Sell
1,957
-1,235
-39% -$28.6K ﹤0.01% 1767
2026
Q1
$65.7K Buy
3,192
+1,264
+66% +$28.5K ﹤0.01% 1648
2025
Q4
$46K Buy
1,928
+494
+34% +$12K ﹤0.01% 1690
2025
Q3
$36K Buy
1,434
+163
+13% +$3.51K ﹤0.01% 1164
2025
Q2
$29K Buy
+1,271
New +$29.4K ﹤0.01% 1355

Other funds holding PRVA

BNP Paribas Asset Management's PRVA Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Privia Health (PRVA) stake by 39% in Q2 2026, selling an estimated $28.6K and leaving 1,957 shares worth $50.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1767.

BNP Paribas Asset Management first reported a position in PRVA in Q2 2025 and has held it in 5 quarters since. The position peaked at $65.7K in Q1 2026. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • BNP Paribas Asset Management held 1,957 shares of Privia Health worth $50.4K as of Q2 2026.
  • BNP Paribas Asset Management sold 1,235 Privia Health shares in Q2 2026, an estimated $28.6K.
  • Privia Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1767 holding.
  • BNP Paribas Asset Management first reported a position in Privia Health in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Privia Health position peaked at $65.7K in Q1 2026.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.